Author:
Maddela Rambabu,Gajula Ramakrishna,Pilli Nageswara Rao,Siddiraju Sridhar,Maddela Srinubabu,Makula Ajitha
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference12 articles.
1. Eltrombopag for the treatment of immune thrombocytopenia;Cheng;Expert Rev. Hematol.,2011
2. Metabolism and disposition of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist, in healthy human subjects;Deng;Drug Metab. Dispos.,2011
3. Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study;Kawaguchi;J. Gastroenterol.,2012
4. Eltrombopag (Promacta), a thrombopoietin receptor agonist for the treatment of thrombocytopenia: current and future considerations;Serebruany;Am. J. Ther.,2010
5. Effect of hepatic or renal impairment on eltrombopag pharmacokinetics;Bauman;J. Clin. Pharmacol.,2011
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献